|
|
|
Insider
Information: |
Green David |
Relationship: |
Interim CEO, Director |
City: |
Holliston |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
2 |
|
Direct
Shares |
1,084,432 |
|
Indirect Shares
|
251,364 |
|
|
Direct
Value |
$3,332,525 |
|
|
Indirect Value
|
$787,316 |
|
|
Total
Shares |
1,335,796 |
|
|
Total
Value |
$4,119,841 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
2
|
0
|
Stock
price went up :
|
2
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
Percentage
Gain/Loss : |
49.2%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Harvard Bioscience Inc |
HBIO |
Director |
2017-02-07 |
925,571 |
2017-02-07 |
234,896 |
Premium* |
|
Biostage Inc |
BSTG |
Interim CEO, Director |
2022-05-12 |
158,861 |
2022-05-12 |
16,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
136 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 3 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-17 |
4 |
OE |
$3.16 |
$56,589 |
D/D |
17,908 |
1,603,195 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-17 |
4 |
S |
$4.10 |
$73,468 |
D/D |
(17,908) |
1,585,287 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-18 |
4 |
S |
$4.08 |
$58,333 |
D/D |
(14,300) |
1,616,933 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-18 |
4 |
OE |
$3.16 |
$145,189 |
D/D |
45,946 |
1,631,233 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-19 |
4 |
OE |
$3.16 |
$152,141 |
D/D |
48,146 |
1,665,079 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-19 |
4 |
S |
$4.04 |
$194,414 |
D/D |
(48,146) |
1,616,933 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-20 |
4 |
OE |
$3.16 |
$232,548 |
D/D |
73,591 |
1,690,524 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-20 |
4 |
S |
$4.05 |
$298,139 |
D/D |
(73,591) |
1,616,933 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-21 |
4 |
S |
$4.06 |
$58,486 |
D/D |
(14,409) |
1,616,933 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2012-12-21 |
4 |
OE |
$3.16 |
$45,532 |
D/D |
14,409 |
1,631,342 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2013-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
41,574 |
1,658,507 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2013-10-18 |
4/A |
OE |
$1.99 |
$1,477,250 |
D/D |
450,000 |
1,546,504 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2013-10-18 |
4 |
D |
$5.50 |
$1,814,148 |
D/D |
(329,845) |
1,478,662 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2013-10-18 |
4 |
OE |
$1.99 |
$1,104,750 |
D/D |
325,000 |
1,546,504 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
President |
|
2013-10-18 |
4 |
OE |
$2.98 |
$372,500 |
D/D |
125,000 |
1,483,507 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2013-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
53,372 |
1,711,881 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2013-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
381,843 |
381,843 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2013-11-01 |
4/A |
A |
$0.00 |
$0 |
I/I |
75,000 |
75,000 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2014-01-09 |
4/A |
D |
$4.75 |
$7,021 |
D/D |
(1,478) |
335,402 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2014-01-09 |
4/A |
D |
$4.70 |
$170,676 |
D/D |
(36,314) |
1,495,721 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2014-01-09 |
4 |
D |
$4.75 |
$7,021 |
D/D |
(1,478) |
380,365 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2014-01-09 |
4 |
D |
$4.70 |
$170,676 |
D/D |
(36,314) |
1,675,567 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2014-03-17 |
4 |
OE |
$8.20 |
$100,540 |
D/D |
12,261 |
347,663 |
0 |
- |
|
BSTG |
Biostage Inc |
Chief Executive Officer |
|
2014-03-17 |
4 |
D |
$10.69 |
$100,529 |
D/D |
(9,404) |
338,259 |
0 |
- |
|
HBIO |
Harvard Bioscience Inc |
Director |
|
2014-04-01 |
4 |
S |
$4.74 |
$203,353 |
D/D |
(42,869) |
1,452,852 |
0 |
- |
|
136 Records found
|
|
Page 3 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|